Join us for an overview the latest updates and advances in Ventilator Associated Pneumonia
Chair: Rajeka Lazarus and Andrew Conway Morris
About this study day:
Join us online on Wednesday 5th of Febuary for an overview of the latest updates and advances in Ventilator Associated Pneumonia
Ventilator-associated pneumonia is the commonest nosocomial infection in intensive care. The past decade has produced a revolution in our understanding of VAP. This study way will provide updates on the prevention, diagnosis and management of VAP, covering the latest evidence.
Running through it will be wider themes of relevance to infection management in the ICU, including the role of antimicrobial stewardship and infection prevention and control. Although aimed at all professionals training in intensive care and microbiology, this study day will also be of interest to more experienced professionals looking for an update or refresher on this important topic.
The learning objectives for this update day are
To understand what VAP is, and how the understanding of it has changed over time
To be aware of current diagnostic approaches to VAP, and how newer technologies will change this over the next decade
To be able to describe the measures used to prevent VAP developing, and understand the pharmacological and non-pharmacological approaches to this.
To be aware of new developments in antimicrobial therapy for VAP and understand how these may alter current practice in this area.
9:30 Zoom Opens: Welcome and Introduction
by Rajeka Lazarus and Andy Conway Morris
9:35 VAP: The evolution of a disease
by Andy Conway Morris
10:00 New antibiotics (beta-lactams/beta-lactamase inhibitors) - what they target/when to use
by Rajeka Lazarus
10:20 How I select antibiotics in VAP, and when I use continuous infusions
by Jeffrey Lipman
10:40 Antibiotic administration after BLING III – practical implementation of continuous infusions (and related pharmacodynamic considerations)
by Reena Mehta
11:00 Discussion
11:20 Coffee Break
11:30 How to diagnose VAP – interactive mini-lectures and panel debate
by Iara-Maria Sequeiros, Kordo Saeed, Richard Pugh
12:45 Lunch
13:30 Preventing VAP – fundamentals of IPC in ICU, the role of physical techniques, antibiotic prophylaxis (respiratory tract) and selective digestive decontamination.
by Ema Swingwood, Lisa Beeson, Nicole Hunfeld, Nazima Pathan
15:00 Coffee Break
15:15 Is it VAP: 3 challenging cases – (interactive case discussion)
by Rajeka Lazarus, Andy Conway Morris, Iara-Maria Sequeiros, Kordo Saeed
16:30 Close out and end of session
Group bookings can be made for multiple delegates and paid by credit card via the event booking page.
We are also able to invoice for group bookings of 10 or more delegates, or where the total value is over £1,000. Group bookings can only be made up to 6 weeks in advance of an event and must be paid in full prior to the event date to avoid tickets being cancelled.
To book a group via invoice, please download the form below, complete and return to events@ics.ac.uk.
If you have any questions about the event or need any further assitance, please do contact us via:
Telephone: (+44) 0207 280 4350
Email:
Consultant clinical microbiologist , University Hospitals Southampton NHS Trust
University Hospitals Bristol
Consultant Pharmacist, Chair of ICS Learning Division & Pharmacy Professional Advisory Group
Anaesthetics and Critical Care, Glan Clwyd Hospital in North Wales
Consultant Intensivist
Dr Conway Morris is a critical care consultant and MRC Clinician Scientist based at the University of Cambridge. He trained at the Universities of Glasgow and Edinburgh, undertaking a PhD in Edinburgh focused on immune failure in critical illness and nosocomial infection. His research interests include neutrophil function and dysfunction in critical illness, where he identified complement component C5a as a key driver of dysfunction in patients. He has also developed and tested a number of diagnostics for pneumonia, using both host and pathogen-focussed techniques. His animating force is a desire to improve the management of infection in intensive care, and combat the rising tide of antimicrobial resistance. He was recently awarded the Royal College of Anaesthetists 2023 Mackintosh Professorship. He is the director of the European Society of Intensive Care Medicine’s research and antimicrobial stewardship learning pathways.
Consultant Physiotherapist, UK
Ema is a Consultant Therapist (Physiotherapist by background) in Critical Care at University Hospitals Bristol and Weston NHS Foundation Trust. Her area of clinical expertise and interest is ventilation, weaning and complex airway clearance.
Having completed the Advanced Cardiorespiratory Physiotherapy Msc programme at University College London (UCL) in 2012, Ema has continued her research focusing on the use of Mechanical Insufflation-Exsufflation (MI-E) and other cough augmentation strategies. Her current PhD work focuses on the use of MI-E in the intubated population which is funded through the NIHR Clinical Academic Research Fellowship pathway.
Extra-curricular activities include contributions to the Undergraduate Physiotherapy programme at the University of the West of England, and post-graduate teachings at University College London and Brunel University. She sits on the Intensive Care Society Physiotherapy Professional Advisory Group and Education Committee, the Equity, Diversity and Belonging Committee of the CSP, and ICUsteps support group network. She has been part of the multi-professional authorship for BTS/ICS documents related to Respiratory Support Units and Weaning Centres. Most recently, she is part of the NHSElect working group for the development of a Critical Care Capability Framework.
Consultant in Microbiology and Infectious Diseases
I am a UKHSA Consultant in Infectious Disease and Microbiology based at the Bristol Royal Infirmary.
I completed my infection training in Oxford and Singapore and I'm the Vice President of the British Infection Society - I have recently initiated a collaboration with the Intensive Care Society to optimise the delivery of infection services within critical care.
I am the microbiology ECMO lead at the Bristol Royal Infirmary.
My other clinical and academic interests are adult vaccines, sustainability in healthcare and tuberculosis.
Consultant Pharmacist, Chair of ICS Learning Division & Pharmacy Professional Advisory Group
Reena is a Consultant Pharmacist in Critical Care at King's College Hospital in London and Chair of the Intensive Care Society's Pharmacy Professional Advisory Group.
She has worked in Critical Care for the past 15 years, leading and managing the Critical Care pharmacy service, providing vision and shaping its future strategy during a period of significant structural change and expansion. She has co-authored and provided specialist input locally & nationally into areas such as pharmacy critical care workforce, clinical guidelines, and advanced critical care training. Reena is a Principal Investigator on a number of NIHR CRN Portfolio studies.
Her specialist areas of interest are the ICU Liberation Bundle (A-F) initiatives, transfer of care around medicines and drug use in extra-corporeal circuits, particularly in renal replacement therapy & ECMO.
Reena is the Pharmacy Lead for the South East London ICS - Critical Care/ODN and a member of the United Kingdom Clinical Pharmacy Association Expert Development Practice Group. She is currently undertaking an MSc in Health Economics, Policy & Management at the London School of Economics and Political Science.